1. ADAMTS-targeting gapmers as a gene modulation strategy in osteoarthritis. Issue 1 (April 2020) Authors: Garcia, J.; Wengel, J.; Howard, K.A.; Creemers, L.B. Journal: Osteoarthritis and cartilage Issue: Volume 28:Issue 1(2020)supplement Page Start: S521 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Fibrin/hyaluronic acid hydrogel for combined delivery of gapmers and chondrocytes as a gene therapy approach for osteoarthritis. (April 2018) Authors: Garcia, J.; Stein, J.; Cai, Y.; Wexselblatt, E.; Creemers, L.; Wengel, J.; Howard, K.; Saris, D.; Yayon, A. Journal: Osteoarthritis and cartilage Issue: Volume 26(2018)Supplement 1 Page Start: S145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Improved RNA cleavage by LNAzyme derivatives of DNAzymes. (1st February 2004) Authors: Vester, B.; Lundberg, L.B.; Sørensen, M.D.; Babu, B.R.; Douthwaite, S.; Wengel, J. Journal: Biochemical Society transactions Issue: Volume 32:Number 1(2004) Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗